1. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
- Author
-
Al-Kharashi LA, Bakheet T, AlHarbi WA, Al-Moghrabi N, and Aboussekhra A
- Subjects
- Animals, Breast Neoplasms genetics, Cancer-Associated Fibroblasts metabolism, Cancer-Associated Fibroblasts pathology, Cell Line, Tumor, Cell Movement drug effects, Cell Proliferation drug effects, DNA (Cytosine-5-)-Methyltransferase 1 metabolism, DNA Methylation drug effects, DNA Methyltransferase 3A metabolism, Decitabine pharmacology, Down-Regulation, Drug Synergism, E2F1 Transcription Factor metabolism, Eugenol pharmacology, Female, Gene Expression Regulation, Neoplastic drug effects, Humans, MCF-7 Cells, Mice, Paracrine Communication drug effects, Xenograft Model Antitumor Assays, Breast Neoplasms drug therapy, Cancer-Associated Fibroblasts drug effects, DNA (Cytosine-5-)-Methyltransferase 1 genetics, DNA Methyltransferase 3A genetics, Decitabine administration & dosage, E2F1 Transcription Factor genetics, Eugenol administration & dosage
- Abstract
Active cancer-associated fibroblasts (CAFs) are major components of the tumor microenvironment, which promote carcinogenesis and modulate response to therapy. Therefore, targeting these cells or reducing their paracrine pro-carcinogenic effects could be of great therapeutic value. To this end, we sought to investigate the effect of eugenol, a natural phenolic molecule, on active breast CAFs. We have shown that decitabine (5-Aza-2'-deoxycytidine, DAC) and eugenol inhibit the expression of the DNA methyltransferase genes DNMT1 and DNMT3A at both the protein and mRNA levels in breast CAF cells. While the effect of eugenol was persistent, DAC had only a transient inhibitory effect on the mRNA level of both DNMT genes. Furthermore, eugenol and DAC suppressed the invasive/migratory and proliferative potential of CAF cells as well as their paracrine pro-carcinogenic effects both in vitro and in humanized orthotopic tumor xenografts. Interestingly, these inhibitory effects of decitabine and eugenol were mediated through E2F1 downregulation. Indeed, ectopic expression of E2F1 upregulated both genes and attenuated the effects of eugenol. Additionally, we provide clear evidence that eugenol, like DAC, strongly modulates the methylation pattern in active CAF cells, through methylating several oncogenes and demethylating various important tumor suppressor genes, which affected their mRNA expression levels. Importantly, the E2F1 promoter was also hypermethylated and the gene downregulated in response to eugenol. Together, these findings show that the active features of breast CAF cells can be normalized through eugenol-dependent targeting of DNMT1/DNMT3A and the consequent modulation in gene methylation., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF